TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Sana Pharma Medical AS
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
65,201
|
55,896
|
65,231 |
| Financial expenses |
3,084
|
1,402
|
1,107 |
| Earnings before taxes |
-9,545
|
-10,330
|
-702 |
| Total assets |
78,218
|
64,946
|
49,769 |
| Current assets |
61,525
|
46,314
|
30,603 |
| Current liabilities |
83,959
|
57,085
|
34,559 |
| Equity capital |
-5,741
|
3,872
|
15,210 |
| - share capital |
29
|
30
|
32 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
-7.3%
|
6.0%
|
30.6% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-14.6%
|
-18.5%
|
-1.1% |
| Return on assets (ROA) |
-8.3%
|
-13.7%
|
0.8% |
| Current ratio |
73.3%
|
81.1%
|
88.6% |
| Return on equity (ROE) |
166.3%
|
-266.8%
|
-4.6% |
| Change turnover |
10,296
|
-5,014
|
-1,936 |
| Change turnover % |
19%
|
-8%
|
-3% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.